<DOC>
	<DOCNO>NCT01161862</DOCNO>
	<brief_summary>The investigator hypothesize closed-loop glucose-control system provide BG control subject type 1 diabetes use estimate BG signal CGM input signal controller .</brief_summary>
	<brief_title>Integration Continuous Glucose Monitoring Into Bi-Hormonal Closed-Loop Artificial Pancreas Automated Management Of Type 1 Diabetes</brief_title>
	<detailed_description>The three specific aim study : Aim 1 : To test safety efficacy control system bi-hormonal configuration regulate BG adult ( 18 year age old ) child ( 12-17 year age ) type 1 diabetes base interstitial-fluid ( ISF ) glucose data CGM . Experiments 51 hour length incorporate 6 meal two ( night ) sleep period . In order evaluate effect exercise BG control , last 48 hour experiment divide two 24 hour block , second contain period structure exercise near begin block . Aim 2 : To test safety efficacy control system insulin-only configuration regulate BG adult ( 18 year age old ) child ( 12-17 year age ) type 1 diabetes base interstitial-fluid ( ISF ) glucose data CGM . Experiments 51 hour length incorporate 6 meal two ( night ) sleep period . In order evaluate effect exercise BG control , last 48 hour experiment divide two 24 hour block , second contain period structure exercise near begin block . Aim 3 : To directly compare performance bi-hormonal insulin-only configuration controller adult ( 18 year age old ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Age 12 year old clinical type 1 diabetes least one year Weight &gt; 41 kg Otherwise healthy ( mild chronic disease allow well control ) Diabetes manage use insulin infusion pump rapid veryrapidacting insulin Body mass index ( BMI ) 20 35 subject &gt; 18 year age BMI 5th 95th percentile age subject &lt; 18 year age Total daily dose ( TDD ) insulin &lt; 1 U/kg Stimulated Cpeptide &lt; 0.1 nmol/L 90 minute liquid mixed meal DCCT protocol Hemoglobin A1c &lt; = 9 % Prescription medication regimen stable 1 month Unable provide inform consent subject &gt; 18 year age unable provide assent &lt; 18 year age Unable comply study procedure Current participation another diabetesrelated clinical trial one primarily observational nature . Potential subject enrol trial passive monitoring equipment exclude . Anemia ( HCT less normal age sex ) Alanine aminotransferase &gt; 3 fold upper limit normal Untreated inadequately treat hyperthyroidism hypothyroidism Pregnancy Renal insufficiency ( creatinine clearance â‰¤ 50 ml/min ) Any known history coronary artery disease Abnormal EKG include , limited evidence active ischemia , prior myocardial infarction , proximal LAD critical stenosis ( Wellen 's sign ) , arrhythmia , tachycardia , prolong QT interval ( &gt; 440 m ) Congestive heart failure History TIA stroke Acute illness exacerbation chronic illness History seizures History pheochromocytoma ( fractionate metanephrines test patient history suggestive pheochromocytoma ) History adrenal disease tumor History pancreatic tumor , include insulinoma History impair gastric motility gastroparesis require pharmacological surgical treatment Current alcohol abuse ( intake average &gt; 3 drink daily last 30 day ) substance abuse ( use within last 6 month control substance without prescription ) Untreated inadequately treat mental illness ( indicator would include symptoms psychosis , hallucination , mania , psychiatric hospitalization last year ) Impaired cognition alter mental status . Hypertension ( blood pressure &gt; 140/90 &gt; 95 % age , height weight subject &lt; 18 year age ) time screen Use medication reduce gastric motility ( e.g . narcotic , antispasmodic , anticholinergic ) . Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible RF interference Use noninsulin , injectable antidiabetic medication History adverse reaction glucagon ( include allergy ) besides nausea vomiting . Established history latex , adhesive , tape allergy Inadequate venous access History allergy aspirin history aspirin intolerance , include Reye syndrome , gastric ulcer bleed associate salicylate Blood dyscrasia bleed diathesis , hemophilia , Von Willebrands disorder , idiopathic thrombocytopenic purpura ( ITP ) Peptic ulcer Unable perform 30 minute moderate exercise treadmill exercise bicycle Unable unwilling discontinue dietary supplement least 2 week prior CRC admission History celiac disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Closed-loop</keyword>
	<keyword>Artificial pancreas</keyword>
	<keyword>Bi-hormonal</keyword>
	<keyword>Insulin</keyword>
	<keyword>Glucagon</keyword>
	<keyword>Diabetes mellitus type 1</keyword>
</DOC>